STOCK TITAN

GrowthStalk Holdings Corp. Acquires 40% of Hash RX, Securing a Category-Leading Solventless Platform and Proven Operating Leadership

Rhea-AI Impact
(Moderate)
Rhea-AI Sentiment
(Very Positive)

GrowthStalk Holdings (OTCID: GSTK) announced on Dec 22, 2025 the acquisition of a 40% equity stake in Hash RX, a solventless cannabis processor based in Oklahoma. The transaction gives GSTK direct ownership of a category‑leading, low‑waste processing platform and access to Hash RX’s operating leadership.

Hash RX is described as having advanced solventless extraction, near‑zero waste operations, lean manufacturing, and institutional cost accounting. GSTK said the stake strengthens its vertical integration, M&A evaluation capabilities, and ability to scale into additional markets as the industry consolidates.

Loading...
Loading translation...

Positive

  • 40% equity stake acquired in Hash RX on Dec 22, 2025
  • Adds solventless processing platform and near‑zero waste model
  • Gains Hash RX management and founder execution expertise
  • Improves GSTK's M&A evaluation and integration capabilities

Negative

  • 40% stake is a minority position, limiting direct control
  • Operating exposure concentrated in Oklahoma market

Oklahoma City, OK, Dec. 22, 2025 (GLOBE NEWSWIRE) -- GrowthStalk Holdings Corp. (“OTCID: GSTK” or the “Company”), a vertically integrated cannabis investment and operations platform, today announced the acquisition of an 40% equity stake in Hash a solventless cannabis producer in Oklahoma, advancing GSTK’s strategy to assemble a scalable, vertically integrated cannabis operating platform.

This transaction represents a strategic inflection point, providing GSTK with direct ownership in a premium processing platform that has demonstrated the ability to outperform in one of the most competitive cannabis markets in the U.S.

A Market Leader Built to Perform Under Pressure

Hash RX, known for its technical innovation, operational excellence, and efficiency. Operating in Oklahoma—where wholesale prices have compressed to near operating margins—Hash Rx has consistently delivered strong performance while many competitors have struggled to remain viable.

This resilience is driven by:

  • Advanced solventless extraction techniques developed and refined in-house

  • A near-zero waste operating model, maximizing value across the entire production lifecycle

  • Lean manufacturing and just-in-time production, optimizing throughput and working capital

  • Institutional-grade cost accounting and process control, enabling disciplined margin management

Together, these capabilities allow Hash Rx to thrive where others merely survive—making it an ideal platform asset for the Company.

Strategic Human Capital as a Competitive Advantage

In addition to acquiring a leading operating platform, GSTK gains the benefit of proven leadership and execution capability through Hash Rx’s management team.

Hash Rx’s founder and CEO Joseph Neihart brings deep, hands-on experience across cultivation, extraction, operations, and supply chain management, with a track record of building and scaling cannabis businesses from the ground up in Oklahoma’s highly competitive market.

GSTK views this operational leadership as a strategic asset, providing:

  • Execution expertise across cultivation, processing, and logistics

  • Data-driven operational decision-making and cost discipline

  • A culture of efficiency, innovation, and continuous improvement

  • A leadership team capable of supporting future acquisitions and integration

This alignment strengthens GSTK’s ability to scale responsibly while maintaining operational excellence across its portfolio.

Positioned for the Next Phase of Industry Evolution

As the cannabis industry continues to consolidate, the Company believes long-term winners will be defined by cost leadership, premium positioning, and execution depth.

By combining GSTK and Hash Rx, the Company brings together operator-level expertise across cultivation, extraction, operations, finance, and supply chain, creating a platform capable of scaling efficiently and evaluating opportunities with discipline. This integration strengthens the Company’s ability to expand into additional markets while enhancing its M&A evaluation and execution capabilities.

Management believes this transaction positions GSTK to capitalize on market normalization and consolidation while building a durable, multi-market platform designed to create lasting shareholder value.

About GrowthStalk Holdings Corp.

GrowthStalk Holdings Corp. is a vertically integrated cannabis operator focused on premium solventless extraction, brand development, and cannabis-specific software infrastructure. The Company’s platform is built around operational discipline, scalable systems, through its 40% ownership of Hash Rx and the launch of Hush & Co.
 www.growthstalk.com

About Hash Rx

Hash Rx is a premier Oklahoma-based solventless extraction lab specializing in live rosin, vape cartridges, and full-melt hash. Known for product quality and compliance, its offerings are distributed through leading dispensaries including The Peak and Elevate.
Instagram: @h.a.s.h.r.x

SAFE HARBOR ACT: Forward-Looking Statements. Except for historical information, the matters discussed herein may be considered “forward-looking” statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended.

Such statements include declarations regarding the intent, belief or current expectations of the Company and its management, including, without limitation, future-oriented statements related to cash flow, gross margins, revenues, and expenses. These statements are based on and reflect our current expectations, estimates, assumptions and/or projections, our perception of historical trends and current conditions, as well as other factors that we believe are appropriate and reasonable under the circumstances. Forward-looking statements generally can be identified by the fact that they do not relate strictly to historical or current facts. They may include forward-looking words such as “expect,” “expectation,” “believe,” “anticipate,” “may,” “could,” “intend,” “belief,” “plan,” “estimate,” “target,” “predict,” “likely,” “seek,” “project,” “model,” “ongoing,” “will,” “should,” “forecast,” “outlook” or similar terminology. Forward-looking statements are subject to a number of risks and uncertainties that may cause the Company’s actual results to differ materially from our intent, belief or current expectations, including, inter alia, the markets for the Company’s products and services, costs of goods and services, other expenses, government regulations, litigations, and general business conditions. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those anticipated, estimated or projected. The Company assumes no obligation to revise or update any forward-looking statements for any reason, except as required by law.

Company Contact:
Steven Earley
(833) 289-4785
grow@growthstalk.com


FAQ

What did GrowthStalk (GSTK) announce on Dec 22, 2025?

GrowthStalk announced it acquired a 40% equity stake in Hash RX, a solventless cannabis processor in Oklahoma.

How does the Hash RX acquisition affect GSTK's operations and M&A strategy?

The stake provides a processing platform, institutional cost controls, and leadership that GSTK says strengthens its M&A evaluation and integration capabilities.

What operational capabilities does Hash RX bring to GSTK (GSTK)?

Hash RX brings advanced solventless extraction, near‑zero waste operations, lean manufacturing, and disciplined cost accounting.

Does GrowthStalk (GSTK) now control Hash RX after the transaction?

No; GSTK acquired a 40% equity stake, which is a minority holding and does not indicate full control.

Where is the Hash RX platform located and why does location matter for GSTK (GSTK)?

Hash RX operates in Oklahoma; the location matters because GSTK gains a platform already operating in a highly competitive, price‑compressed market.
Growth Stalk Holdings

OTC:GSTK

GSTK Rankings

GSTK Latest News

GSTK Stock Data

57.11M
6.79M
Drug Manufacturers - Specialty & Generic
Healthcare
Link
United States
Seminole